New York State Common Retirement Fund
RAPT

New York State Common Retirement Fund’s RAPT Therapeutics RAPT Stock Holding History

New York State Common Retirement Fund’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,444
Closed -$14.1K – 3312
2025
Q1 		$14.1K Hold
1,444
– – ﹤0.01% 3031
2024
Q4 		$18.2K Hold
1,444
– – ﹤0.01% 3053
2024
Q3 		$23.2K Hold
1,444
– – ﹤0.01% 3024
2024
Q2 		$35.2K Hold
1,444
– – ﹤0.01% 3159
2024
Q1 		$104K Hold
1,444
– – ﹤0.01% 2722
2023
Q4 		$287K Sell
1,444
-7
-0.5% -$867 ﹤0.01% 2311
2023
Q3 		$193K Buy
1,451
+10
+0.7% +$1.63K ﹤0.01% 2447
2023
Q2 		$216K Sell
1,441
-613
-30% -$95.5K ﹤0.01% 2458
2023
Q1 		$301K Sell
2,054
-487
-19% -$98.5K ﹤0.01% 2425
2022
Q4 		$402K Hold
2,541
– – ﹤0.01% 2418
2022
Q3 		$489K Buy
2,541
+8
+0.3% +$1.51K ﹤0.01% 2334
2022
Q2 		$370K Buy
2,533
+646
+34% +$86.1K ﹤0.01% 2502
2022
Q1 		$332K Buy
1,887
+43
+2% +$8.12K ﹤0.01% 2598
2021
Q4 		$542K Buy
1,844
+259
+16% +$69.2K ﹤0.01% 2398
2021
Q3 		$394K Sell
1,585
-351
-18% -$92.8K ﹤0.01% 2599
2021
Q2 		$492K Buy
1,936
+673
+53% +$126K ﹤0.01% 2599
2021
Q1 		$224K Hold
1,263
– – ﹤0.01% 2794
2020
Q4 		$199K Hold
1,263
– – ﹤0.01% 2761
2020
Q3 		$325K Hold
1,263
– – ﹤0.01% 2432
2020
Q2 		$293K Buy
1,263
+1,100
+675% +$170K ﹤0.01% 2477
2020
Q1 		$28K Sell
163
-300
-65% -$68.3K ﹤0.01% 3073
2019
Q4 		$102K Buy
+463
New +$85.2K ﹤0.01% 3002

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

New York State Common Retirement Fund's RAPT Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of RAPT Therapeutics (RAPT) in Q2 2025, closing a stake of 1,444 shares — an estimated $14.1K sold.

New York State Common Retirement Fund first reported a position in RAPT in Q4 2019 and held it in 22 quarters. The position peaked at $542K in Q4 2021. 50 funds tracked by Wall St. Rank hold RAPT as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining RAPT Therapeutics position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 1,444 RAPT Therapeutics shares in Q2 2025, an estimated $14.1K.
  • New York State Common Retirement Fund first reported a position in RAPT Therapeutics in Q4 2019 and held it in 22 quarters.
  • New York State Common Retirement Fund's RAPT Therapeutics position peaked at $542K in Q4 2021.
  • 50 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.